IGC Pharma (FRA:IGS1) Days Inventory : 2,972.64 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is IGC Pharma Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). IGC Pharma's Average Total Inventories for the three months ended in Dec. 2023 was €2.12 Mil. IGC Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was €0.07 Mil. Hence, IGC Pharma's Days Inventory for the three months ended in Dec. 2023 was 2,972.64.

The historical rank and industry rank for IGC Pharma's Days Inventory or its related term are showing as below:

FRA:IGS1' s Days Inventory Range Over the Past 10 Years
Min: 26.88 Med: 130.84 Max: 8114.51
Current: 1679.99

During the past 13 years, IGC Pharma's highest Days Inventory was 8114.51. The lowest was 26.88. And the median was 130.84.

FRA:IGS1's Days Inventory is ranked worse than
94.34% of 654 companies
in the Biotechnology industry
Industry Median: 192.63 vs FRA:IGS1: 1679.99

IGC Pharma's Days Inventory increased from Dec. 2022 (1,540.32) to Dec. 2023 (2,972.64). It might indicate that IGC Pharma's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. IGC Pharma's Inventory Turnover for the three months ended in Dec. 2023 was 0.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. IGC Pharma's Inventory-to-Revenue for the three months ended in Dec. 2023 was 11.32.

IGC Pharma Days Inventory Historical Data

The historical data trend for IGC Pharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGC Pharma Days Inventory Chart

IGC Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Inventory

Get a 7-Day Free Trial

25.36

206.96

2,338.44

7,760.22

2,374.17

IGC Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															1,540.32	2,858.22	809.39	2,035.70	2,972.64

Competitive Comparison of IGC Pharma's Days Inventory

For the Biotechnology subindustry, IGC Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IGC Pharma's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IGC Pharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where IGC Pharma's Days Inventory falls into.

IGC Pharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

IGC Pharma's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as

	Days Inventory (A: Mar. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2022 )	+	Total Inventories (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (3.222	+	2.476)	/	2 )	/	0.438	*	365
=	2.849					/	0.438	*	365
=	2,374.17

IGC Pharma's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (2.47	+	1.765)	/	2 )	/	0.065	*	365 / 4
=	2.1175					/	0.065	*	365 / 4
=	2,972.64

IGC Pharma (FRA:IGS1) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

IGC Pharma's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.065	/	2.1175
	=	0.03

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

IGC Pharma's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2.1175	/	0.187
	=	11.32

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

IGC Pharma Days Inventory Related Terms

Thank you for viewing the detailed overview of IGC Pharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

IGC Pharma (FRA:IGS1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGC Pharma Inc (FRA:IGS1) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

IGC:USA

Address

10224 Falls Road, Potomac, MD, USA, 20854

Website

https://www.igcinc.us

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

IGC Pharma (FRA:IGS1) Headlines

No Headlines